Nuvectis Pharma, Inc. (NVCT) stock
NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.20+0.09 (+0.47%)
Close on Nov 17, 2026Market cap $625.57MP/E –Yield 0.00%
Nuvectis Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Nuvectis Pharma's price to book ratio was 61.7× on Nov 11, 2026, against 6.7× a year earlier. Over the last 5 years it ranged from 5.3× to 66.8×, with a median of 10.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 61.7× | +53.7 |
| 2025 | Dec 31, 2025 | 8.1× | −1.3 |
| 2024 | Dec 31, 2024 | 9.3× | +0.7 |
| 2023 | Dec 29, 2023 | 8.7× | +3.3 |
| 2022 | Dec 30, 2022 | 5.4× | – |
See a number that looks wrong?